Journal Information
Vol. 16. Issue 1.
Pages 1-8 (January - February 2012)
Share
Share
Download PDF
More article options
Vol. 16. Issue 1.
Pages 1-8 (January - February 2012)
Open Access
Angina pectoris in patients with HIV/AIDS: Prevalence and risk factors
Visits
3075
Josefina Cláudia Zirpolia,
Corresponding author
claudiazirpoli@cardiol.br

Corresponding author at: Av. Prof. Moraes Rêgo, s/n, Cidade Universitária, Recife, PE, 50670-420, Brazil.
, Heloisa Ramos Lacerdaa,b, Valéria Maria Gonçalves de Albuquerqueb, Maria de Fátima Pessoa Militão de Albuquerquec, Demócrito de Barros Miranda Filhob, Verônica Soares Monteirob, Isly Lucena de Barrosa, Evanízio Roque de Arruda Juniord, Ulisses Ramos Montarroyosa, Ricardo Arraes de Alencar Ximenesa,b
a Universidade Federal de Pernambuco, Recife, PE, Brazil
b Universidade de Pernambuco, Recife, PE, Brazil
c Centro de Pesquisa Aggeu Magalhães, Recife, PE, Brazil
d Universidade Federal da Paraíba, João Pessoa, PB, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract
Introduction

The incidence of ischemic heart disease is higher in patients with HIV/AIDS. However, the frequency of angina pectoris in these patients is still not known. Literature about this subject is still scarce.

Objective

To evaluate the prevalence of angina pectoris and risk factors for coronary disease and to examine the association between traditional risk factors and HIV-related risk factors and angina pectoris.

Method

An epidemiological cross-sectional study, analyzed as case-control study, involving 584 patients with HIV/AIDS. Angina pectoris was identified by Rose questionnaire, classified as definite or possible. Information regarding risk factors was obtained through a questionnaire, biochemical laboratory tests, medical records and anthropometric measures taken during consultations at AIDS treatment clinics in Pernambuco, Brazil, from June 2007 to February 2008. To adjust the effect of each factor in relation to others, multiple logistic regression was used.

Results

There was a preponderance of men (63.2%); mean ages were 39.8 years for men, 36.8 years for women. The prevalence of definite and possible angina were 11% and 9.4%, respectively, totaling 20.4%, with independent associations between angina and smoking (OR = 2.88; 95% CI: 1.69-4.90), obesity (OR = 1.62; 95% CI: 0.97-2.70), family history of heart attack (OR = 1.70; 95% CI: 1.00-2.88), low schooling (OR = 2.11; 95% CI: 1.24-3.59), and low monthly income (OR = 2.93; 95% CI: 1.18-7.22), even after adjustment for age.

Conclusion

This study suggests that angina pectoris is underdiagnosed, even in patients with medical monitoring, revealing lost opportunities in identification and prevention of cardiovascular morbidity.

Keywords:
Acquired immunodeficiency syndrome
Angina pectoris
Coronary disease
Risk factors
Full text is only aviable in PDF
References
[1.]
L.A. Hajjar, D. Calderaro, P.C. Yu, et al.
Manifestações cardiovasculares em pacientes com infecção pelo vírus da imunodeficiência humana.
Arq Bras Cardiol, 85 (2005), pp. 363-367
[2.]
G. Barbaro.
Cardiovascular manifestations of HIV infection.
Circulation, 106 (2002), pp. 1420-1425
[3.]
The Antiretroviral Therapy Cohort Collaboration.
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
[4.]
S.A. Bozzete, C.F. Ake, H.K. Tam, et al.
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
NEJM, 348 (2003), pp. 702-710
[5.]
M. Mary-Krause, L. Cotte, A. Simon, M. Partisani, D. Costagliola.
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.
[6.]
F. Dronda.
Riesgo vascular en pacientes con infección crónica por el VIH-1: controversias con implicaciones terapéuticas, clínicas y pronósticas.
Enferm Infecc Microbiol Clin, 22 (2004), pp. 40-45
[7.]
K.G. Donati, R. Rabagliati, L. Lacoviello, et al.
HIV infection HAART, and endothelial adhesion molecules: current perspectives.
Lancet Infect Dis, 4 (2004), pp. 213-222
[8.]
J.J. Monsuez, B. Gallet, L. Escaut, et al.
Clinical outcome after coronary events in patients treated with HIV – protease inhibitors.
Eur Heart J, 21 (2000), pp. 2079-2080
[9.]
B. Caramelli, C.Y.S.M. Bernoche, A.M. Sartori, et al.
Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate.
Braz J Infect Dis, 5 (2001), pp. 332-338
[10.]
S. Grover, L. Coupal, N. Gilmore.
Impact of dyslipidemia associated with highly active antiretroviral therapy (HAART) on cardiovascular risk and life expectancy.
Am J Cardiol, 95 (2005), pp. 586-591
[11.]
P.C. Yu, D. Calderaro, E.M.O. Lima, et al.
Terapia hipolipemiante em situações especiais – síndrome da imunodeficiência adquirida.
Arq Bras Cardiol, 85 (2005), pp. 58-60
[12.]
J.E. Ho, P.Y. Hsue.
Cardiovascular manifestations of HIV infection.
Heart, 95 (2009), pp. 1193-1202
[13.]
V. Rickerts, H. Brodt, S. Staszewski, et al.
Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study.
Eur J Med Res, 5 (2000), pp. 329-333
[14.]
A.M.M. Valente, A.F. Reis, D.M. Machado, et al.
Alterações metabólicas da Síndrome Lipodistrófica do HIV.
Arq Bras Endocrinol Metabol, 49 (2005), pp. 871-881
[15.]
V.A. Triant, H. Lee, C. Hadigan, et al.
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.
J Clin Endocrinol Metab, 92 (2007), pp. 2506-2512
[16.]
J. Bodegard, G. Erikssen, J.V. Bjornholt, et al.
Possible angina detected by the WHO angina questionnaire in apparently healthy men with a normal exercise ECG: coronary heart disease or not? A 26 year follow-up study.
Heart, 90 (2004), pp. 627-632
[17.]
G.A. Rose, H. Blackburn.
Cardiovascular survey methods.
WHO, 56 (1968), pp. 1-188
[18.]
Ministério da Saúde do Brasil. Inquérito Domiciliar sobre Comportamentos de Risco e Morbidade Referida de Doenças e Agravos Não-Transmissíveis em 15 Capitais Brasileiras. INCA/SVS/MS. 2003. http://bvsms.saude.gov.br/bvs/publicacoes/inca/inquerito22_06_parte1.pdf.
[19.]
H. Hemingway, C. Langenberg, J. Damant, et al.
Prevalence of angina in women versus men – A systematic review and meta-analysis of international across 31 countries.
Circulation, 117 (2008), pp. 1526-1536
[20.]
N. Friis-Møller, R. Weber, P. Reiss, et al.
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study.
[21.]
T. Neumann, T. Woiwod, A. Neumann, et al.
Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients, part II: gender differences.
Eur J Med Res, 9 (2004), pp. 55-60
[22.]
A.S. Moraes, J.M.P. Souza.
Diabetes mellitus e doença isquêmica do coração: estudo tipo caso-controle.
Rev Saúde Pública, 30 (1996), pp. 364-371
[23.]
A. Avezum, L.S. Piegas, J.C.R. Pereira.
Fatores de risco associados com infarto do miocárdio na região metropolitana de São Paulo: uma região desenvolvida em um país em desenvolvimento.
Arq Bras Cardiol, 84 (2005), pp. 206-213
[24.]
N. Friis-Møller, P. Reiss, C.A. Sabin, DAD Study Group, et al.
Class of antiretroviral drugs and the risk of myocardial infarction.
N Engl J Med, 356 (2007), pp. 1723-1735
[25.]
A.C. Spósito, B. Caramelli, A.M. Sartori, et al.
The Lipoprotein Profile in HIV Infected Patients.
Braz J Infect Dis, 1 (1997), pp. 275-283
[26.]
P.M. Coplan, A. Nikas, A. Japour, et al.
Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.
AIDS Res Hum Retroviruses, 19 (2003), pp. 449-455
[27.]
Brazilian Ministry of Health, National Program of STD/AIDS 2008. Consensus for the treatment of adults and adolescents with HIV infection, Brasília, 120pp.
[28.]
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the national Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
JAMA, 285 (2001), pp. 2486-2496
[29.]
A.V. Chobanian, G.L. Bakris, H.R. Black, et al.
The seventh report of the Join National Committee on prevention, detection, eva-luation, and treatment of high blood pressure.
Hypertension, 42 (2003), pp. 1206-1252
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools